Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

The sickle cell treatment voxelotor (Oxbryta) has been withdrawn from all markets by the manufacturer Pfizer after a “higher than anticipated” number of deaths were reported and clinical evidence ...

Pfizer recalled Oxbryta and ended clinical trials over safety concerns, but sickle cell advocates are warning that stopping the drug abruptly could be dangerous.

Healthcare professionals have been urged to stop supplying Oxbryta “immediately” after new data revealed “an unfavourable imbalance” of “fatal events” and “acute painful crises” in patients on the ...

Pfizer has divested a $3.3 billion stake in Haleon, reducing its holding in the British consumer healthcare company.

A Johns Hopkins analysis commissioned by STAT shows that the rate of postpartum sterilization is significantly higher in ...

The questions of drugs, real and spurious, has come up in the healthcare sector this week, with reports of drugs not meeting quality standards, pharmaceutical companies claiming that these drugs were ...

Three percent are undecided. The survey, completed from Sept. 17 to 24 by landline, cell phone and text-to-web, is the first conducted by AARP in the state since President Joe Biden dropped out of ...

Legislators in Kenya have started the process of removing the country's deputy president from office. Africans studying in Beirut are having to weigh up whether or not they should leave the ...

The attack, which ended shortly after it began, capped a chaotic 24-hour period that began with Israel’s invading of Lebanon in pursuit of Hezbollah. Iran fired a barrage of ballistic missiles ...

The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the development of its omics-based technology for use in biomedicine, agritech and ...